glp-1+nad GLP-1 and NAD+ NAD+ & GLP-1 Program in
Description
- , , -4
At maintenance doses of 2.4 mg/week = 1.2 ml = 120 units
Identify patients with vagal involvement Track their symptom clusters Measure their response Separate them from other long-COVID phenotypes Without this, every study runs the risk of being written off before the true signal is even discovered
M., Dietz W
